Page last updated: 2024-08-21

malondialdehyde and Respiration Disorders

malondialdehyde has been researched along with Respiration Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badry, R; Farghaly, HS; Othman, HA; Saad, K1
Calik, M; Kandemir, H; Oguz, E; Sarikaya, S; Yoldas, TK1
Khan, SA; Kumar, GK; Nanduri, J; Peng, YJ; Prabhakar, NR; Semenza, GL; Wang, N1
Belch, J; Carter, R; el-Fiky, M; Martin, W; McLaren, M; McQuiston, AM; Tweddel, A; Wheatley, DJ1
Kodama , S; Mikawa, K; Nishina, K; Obara, H1
Kodama, SI; Mikawa, K; Nishina, K; Obara, H1

Trials

2 trial(s) available for malondialdehyde and Respiration Disorders

ArticleYear
Respiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1996, Volume: 10, Issue:9

    Topics: Blood Gas Analysis; Cardiopulmonary Bypass; Complement Activation; Complement C3a; Humans; Leukocyte Elastase; Malondialdehyde; Middle Aged; Oxygenators; Respiration Disorders; Thromboxane B2; Time Factors; von Willebrand Factor

1996
ONO-1714, a new inducible nitric oxide synthase inhibitor, attenuates diaphragmatic dysfunction associated with cerulein-induced pancreatitis in rats.
    Critical care medicine, 2001, Volume: 29, Issue:6

    Topics: Amidines; Analysis of Variance; Animals; Ceruletide; Diaphragm; Disease Models, Animal; Enzyme Inhibitors; Heterocyclic Compounds, 2-Ring; Immunohistochemistry; Lipid Peroxidation; Male; Malondialdehyde; Muscle Contraction; Nitric Oxide; Pancreatitis; Prospective Studies; Rats; Rats, Sprague-Dawley; Respiration Disorders; Statistics, Nonparametric

2001

Other Studies

4 other study(ies) available for malondialdehyde and Respiration Disorders

ArticleYear
Selenium and antioxidant levels decreased in blood of children with breath-holding spells.
    Journal of child neurology, 2014, Volume: 29, Issue:10

    Topics: Antioxidants; Case-Control Studies; Child, Preschool; Female; Glutathione Peroxidase; Humans; Infant; Male; Malondialdehyde; Respiration Disorders; Selenium; Superoxide Dismutase

2014
Melatonin Can Be Used to Treat Childhood Breath-Holding Spells.
    Journal of child neurology, 2015, Volume: 30, Issue:8

    Topics: Antioxidants; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Respiration Disorders; Selenium; Superoxide Dismutase

2015
Epigenetic regulation of redox state mediates persistent cardiorespiratory abnormalities after long-term intermittent hypoxia.
    The Journal of physiology, 2017, 01-01, Volume: 595, Issue:1

    Topics: Aconitate Hydratase; Adrenal Medulla; Animals; Blood Pressure; Carotid Body; Catalase; DNA Methylation; Epigenesis, Genetic; Gene Expression; Glutathione Peroxidase; Hypertension; Hypoxia; Male; Malondialdehyde; Norepinephrine; Oxidation-Reduction; Peroxiredoxins; Rats, Sprague-Dawley; Reactive Oxygen Species; Respiration Disorders; Superoxide Dismutase; Superoxide Dismutase-1

2017
ONO1714, a new inducible nitric oxide synthase inhibitor, attenuates sepsis-induced diaphragmatic dysfunction in hamsters.
    Anesthesia and analgesia, 2001, Volume: 92, Issue:4

    Topics: Amidines; Animals; Cricetinae; Diaphragm; Enzyme Inhibitors; Heterocyclic Compounds, 2-Ring; Immunohistochemistry; In Vitro Techniques; Malondialdehyde; Mesocricetus; Muscle Contraction; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Respiration Disorders; Sepsis; Tyrosine

2001